Log In Get Started
Press Releases April 5, 2026

Celestica Q1 2026 Financial Results and Conference Call Tuesday, April 28, 2026

Celestica Announces Q1 2026 Financial Results Release and Conference Call

By Nina Shah CLS
Celestica Q1 2026 Financial Results and Conference Call Tuesday, April 28, 2026
CLS

Celestica Inc. will release its financial results for the first quarter of 2026 after market close on April 27, 2026, followed by a conference call on April 28, 2026. Investors and interested parties can join the live webcast or access a recording afterward.

Key Points

  • Celestica's Q1 2026 financial results will be publicly available on April 27, 2026, after the market closes.
  • The company will host a conference call and webcast the following morning for investor participation.
  • The webcast recording will be accessible on Celestica's official website for those unable to attend live.

TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX and NYSE: CLS) will release its first quarter 2026 financial results after market close on Monday, April 27, 2026, and will host a conference call at 8:00am ET on Tuesday, April 28, 2026.

Participants are invited to join the live webcast at the following link.

For those unable to participate, a recorded webcast will be available approximately two hours after completion of the call. To access the recorded webcast visit www.celestica.com.

Contact

Celestica Investor Relations
[email protected]


Risks

  • Market reaction to financial results could introduce volatility in the technology and electronics manufacturing sectors.
  • Potential for unforeseen operational or market challenges impacting future financial performance.
  • Dependence on timely dissemination of financial information to maintain investor confidence.

More from Press Releases

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential Apr 7, 2026 Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit Apr 7, 2026 Director/PDMR Shareholding Apr 7, 2026 Oculis to Participate in Upcoming Investor Conferences Apr 7, 2026 Pharming Group to participate in April investor conferences Apr 7, 2026